The Epoch Times
The Epoch Times
AD
The Epoch Times
Social Issues

Australia to Stop Pharmacists Making DIY Ozempic

Pharmacists have been making copies of weight loss drugs such as Ozempic and Mounjaro, but this is putting patients at risk, according to the TGA.
Google LogoMark Us Preferred on Google
Australia to Stop Pharmacists Making DIY Ozempic
Joel Sage/AFP via Getty Images
Rex Widerstrom
Rex Widerstrom
5/22/2024|Updated: 5/22/2024
0:00

The Australian government is set to ban pharmacists from compounding replicas of popular weight loss drugs such as Ozempic and Mounjaro, citing safety concerns.

Compounding is a process whereby a pharmacist mixes various ingredients to emulate another drug. It is usually done because the medicine needs to be tailored to suit a particular patient, such as someone who may be allergic to a particular ingredient or needs a different dose than is commercially available.

Google LogoMark Us Preferred on Google
Rex Widerstrom
Rex Widerstrom
Author
Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio.
Author’s Selected Articles
Fathers Say Economic Pressure Stopping Them Being the Parent They Want to Be
May 15, 2026
Fathers Say Economic Pressure Stopping Them Being the Parent They Want to Be
Budget Locks in NDIS Cuts as Labor Tries to Rein in $38 Billion in Costs
May 13, 2026
Budget Locks in NDIS Cuts as Labor Tries to Rein in $38 Billion in Costs
Australia’s Net Debt to Reach $616.6 billion in 2026-27
May 12, 2026
Australia’s Net Debt to Reach $616.6 billion in 2026-27
Labor to Tax Family Trusts in Overhaul of Wealth Creation Channels for Australians
May 12, 2026
Labor to Tax Family Trusts in Overhaul of Wealth Creation Channels for Australians
Related Topics
Australia
FDA - Food and Drug Administration
Therapeutic Goods Administration
Ozempic
compound medicines
Pharmacy Board of Australia
AD
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.